维普期刊资源整合服务平台（V6.5）

92篇 您的检索式：作者名="BATES GW"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Intravenous tissue-type plas- minogen activator for treatment of acute stroke : the standard treatment with alteplase to reverse stroke ( STARS ) study 显示文摘	Albers GW Bate VE Clark WE	2000	JAMA2000，283，：	1
2	Adhesion prevention in patients with m- ultiple cesarean deliveries 显示文摘	Bates GW Jr Shomento S	2011	Am J Obstet Gynecol2011，205，6：	1
3	Pregnancy after successful vaginoplasty and cervical stenting for partial atresia of thecervix显示文摘	Hampton HL Meeks GR Bates GW	1990	Obstet Gynecol1990，76，52：	1
4	Inhibitory proteoglycan immunoreactivity is higher at the caudal than the rostral schwann cell grafttransected spinal cord interface 显示文摘	Plant GW Bates ML Bunge MB	2001	Mol Cell Neurosci2001，17，3：	1
5	Reproductive outcomes after medical and surgical management of ectopic pregnancy 显示文摘	Juneau C Bates GW	2012	Clin Obstet Gyneco12012，55，2：	1
6	Intravenous tissue-type plasminogen activator for treatment of acute stroke: the standard treatment with alteplase to reverse stroke (STARS) study显示文摘	Albers GW Bates VE Clark WE	2000	JAMA2000，283，：	1
7	Intravenous tissue-type plasminogen for treatment of acute stroke:the standard treatment with alteplase to reverse stroke(STARS)study显示文摘	Bates VE Clark WM	2000	JAMA2000，283，9：	1
8	Inhibitory proteoglycan immunoreactivity is higer at the caudal than the rostral Schwann cell graft-transected spinal cord interface显示文摘	Plant GW Bates ML Bunge MB	2001	Mol Cell Neurosci2001，17，3：	1
9	Intravenous tissue-type plasminogen activator for treatment of acute stroke:The Standard Treatment with Alteplase to Reverse Stroke(STARS)study显示文摘	Albers GW Bates VE Clark WM	2000	JAMA2000，283，9：	1
10	Intravenous tissue - type piasminogen activator for treatment of acute stroke: the Standard Treatment with Aheplase to Reverse Stroke (STARS) study 显示文摘	Albers GW Bates VE Clark WM	2000	JAMA2000，283，9：	1
11	Longterm management of Polyeystic Ovarian Syndrome(PCOS) 显示文摘	Bates GW Legro RS	2013	Molecular and cellular endocrinology2013，373，12：	1
12	Inhibitory proteoglycan immunoreactivity is higher at the caudal than the rostral Schwann cell graft-transected spinal cord interface 显示文摘	Plant GW Bates ML Bunge MB	2001	Mol Cell Neurosci2001，17，3：	1
13	A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer显示文摘	Propst AM Bates GW Robinson RD	2006	Fertil Steril2006，86，1：	1
14	Intravenous tissue - type piasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke(STARS) studv显示文摘	Albers GW Bates VE Clark WM	2000	JAMA2000，283，9：	1
15	Wright M J,Martin NG,Genetic variance in a component of the language acquisition device:ROBO1 polymorphisms associated with phonological buffer deficits显示文摘	Bates TC Luciano M Medland SE Montgomery GW		0，，01：	1
16	Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function显示文摘	Bjornholm M Münzberg H Leshan RL Villanueva EC Bates SH Louis GW Jones JC Ishida-Takahashi R Bjorbaek C Myers MG Jr		0，，：	1
17	Inhibitory proteoglycan immunoreactivity is higher at the caudal than rostral schwann cell graft-transected spinal cord interface显示文摘	Plant GW Bates ML Bunge MB	2001	Mol Cell Neurosci2001，17，3：	1
18	Intravenous tissue-type plasminogen activator for treatment of acute stroke:the standard treatment with alteplase to reverse stroke(STARS)study显示文摘	Albers GW Bate VE Clark WE	2000	JAMA2000，283，：	1
19	Inhibitory p roteoglycan immuno-reactivity is higher at the caudal than the rostral Schwann cellgraft-transected spinal cord interface 显示文摘	Plant GW Bates ML Bunge MB	2001	Mol Cell Neurosci2001，17，3：	1
20	Inhibitory proteoglycan immunoreactivity is higher at the caudal than the rostral Schwann cell graft-transected spinal cord interface显示文摘	Plant GW Bates ML Bunge MB	2001	Mol Cell Neurosci2001，17，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示